BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Li X, Dong Y, Fan Y, Cheng Y, Zhai L, Zhang S, Zhou J, Wang J. Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer. Front Endocrinol (Lausanne) 2021;12:780769. [PMID: 34975754 DOI: 10.3389/fendo.2021.780769] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Liu H, Han X, Tang Y. Analysis of risk factors for sentinel lymph node metastasis in patients with endometrial cancer. Am J Transl Res 2022;14:8650-8. [PMID: 36628225] [Reference Citation Analysis]
2 Chen M, Lin H, Liang J, Wu M, Li J, Wang L. Association between subtypes of metabolic syndrome and prognosis in patients with stage I endometrioid adenocarcinoma: A retrospective cohort study. Front Oncol 2022;12:950589. [DOI: 10.3389/fonc.2022.950589] [Reference Citation Analysis]
3 Ding Y, Fan Y, Li X, Wang Y, Wang J, Tian L. Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients. Reprod Biol Endocrinol 2022;20:134. [PMID: 36064542 DOI: 10.1186/s12958-022-01006-0] [Reference Citation Analysis]
4 Lin Q, Lu Y, Lu R, Chen Y, Wang L, Lu J, Ye X. Assessing Metabolic Risk Factors for LVSI in Endometrial Cancer: A Cross-Sectional Study. Ther Clin Risk Manag 2022;18:789-98. [PMID: 35971461 DOI: 10.2147/TCRM.S372371] [Reference Citation Analysis]